Extended interval oral cholera vaccine trial in Kenya
Part of Infections clinical trials.
This trial tests giving the oral cholera vaccine on a longer dosing schedule than usual. It aims to see if a longer gap between doses still works well to protect people from cholera, especially helpful in places where returning for a second dose is hard.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must live in Mukuru, Nairobi, Kenya.
- You must be at least 1 year old.
- You must be in good general health, without severe or untreated long-term illnesses.
- You cannot be pregnant. Women of childbearing age will need a pregnancy test.
- You must not have had a cholera vaccine or cholera disease in the past 2 years.
- You must not have severe malnutrition or a condition that weakens the immune system.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new cholera vaccine in healthy people ages 1 to 45. It aims to see if the vaccine is safe and creates a good immune response.
This trial tests a new cholera vaccine (Biovac OCV-S) to see if it works as well as the current vaccine (Euvichol-Plus). It is for healthy people aged 1 to 45, and also for adults with HIV who are on treatment.
This trial tests a new oral vaccine designed to protect against cholera. It is for healthy adults aged 18-45 who want to help evaluate the vaccine's safety and immune response. Participation involves receiving the vaccine and attending follow-up visits.
This study tests an oral cholera vaccine called PanChol in healthy adults. The goal is to see if it's safe and how the body responds. It may help protect against cholera, a serious diarrheal illness.
This trial is for children aged 2 to 14 who have not had a cholera vaccine before. It tests a safe, oral vaccine to prevent cholera, a serious diarrheal disease.
This study tests an oral cholera vaccine to see how it affects your gut bacteria, inflammation, and bowel habits. Participation may help researchers understand how the vaccine works in real-world populations.
Hear when a new Cholera Vaccination trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.